who owns pfizer

Pfizer is owned by a mix of institutional investors, insiders, and public shareholders. The top individual/insider shareholders include Albert Bourla (chairman and CEO), Mikael Dolsten (retired chief scientific officer), and Douglas Lanker (executive vice president). However, insiders own only about 0.06% of the shares. The majority ownership lies with institutional investors, notably Vanguard Group, BlackRock Inc., and State Street Corp., who together hold a significant portion of Pfizer's shares, approximately 67.74% as of the end of 2024. Public shareholders and other entities own the remaining shares.